Bristol-Myers Squibb Company
TREATMENT OF LUNG CANCER USING AN ANTI-FUCOSYL-GM1 ANTIBODY

Abstract:

This disclosure provides a method for treating a subject afflicted with a lung cancer, which method comprises administering to the subject a therapeutically effective amount of an antibody or an antigen-binding portion thereof that specifically binds to Fucosyl-GM1.